newsfilter
← Latest News
PR Newswire·

Innocan Pharma Unveils Groundbreaking Veterinary Breakthroughs at EAVPT 2023 Congress

HERZLIYA, Israel and CALGARY, AB, June 22, 2023 /CNW/ -- Innocan Pharma Corporation (CSE:INNO) (FSE: IP4) (OTCQB:INNPF), a leading innovator in pharmaceutical solutions for Human & Animal health, proudly announces